Teladoc Health - AI Stock Analysis

Analysis generated January 27, 2026

Teladoc Health is a leading provider of telemedicine and virtual healthcare services. The company leverages advanced technology and a vast network of medical professionals to deliver a range of healthcare services, including general medical consultations, mental health care, and specialist consultations. As the demand for remote health services expands, Teladoc Health positions itself as a key player in reshaping the healthcare delivery model.

Fundamental Analysis

Teladoc Health reported revenue of $626 million for the last quarter. This figure is crucial because it represents a slight decrease of 0.86% from the previous quarter and a 2.20% drop compared to the same quarter last year. The decline in revenue is a concern as it shows the company might be struggling to grow its top-line revenue.

Net income for the last quarter was $50 million, marking a 51.58% decrease compared to the previous quarter and a 48.78% drop compared to the same quarter last year. This substantial decline signals issues in profitability and raises questions about the company's operational efficiencies and cost management.

EBITDA for the last quarter stood at $35 million, showing a drastic decrease of 1,415.21% from the previous quarter and a decrease of 362.73% from the same quarter last year. Such a significant reduction indicates potential business challenges and prompts concerns over cash flow and earnings sustainability.

Adding to the concerns, there have been recent instances of company insiders selling their stock. Insider selling can be a bearish signal, indicating that those closest to the company may have concerns about its future performance.

Technical Analysis

Today's stock price of Teladoc Health is $6.08. The price has decreased by 14.61% compared to a month ago and by 42.21% compared to a year ago. This notable long-term decline highlights the bearish trend and indicates potential concerns about the company's market standing.

The current Simple Moving Average (SMA10) is 6.25, slightly lower than the previous SMA10 of 6.27. This decrease suggests a potential downward trend in the stock's price movement.

Additionally, the Relative Strength Index (RSI) stands at 74.7, which indicates a potentially overbought condition and aligns with bearish trends, suggesting future price declines.

Alternative Data Analysis

Teladoc Health currently has 58 open positions listed on popular job boards, marking a 33% decrease over the last couple of months. This decrease likely reflects efforts to improve margins or cut costs, which may not be a positive sign for a company focused on growth.

The business outlook among Teladoc Health's employees is low, with only 33% positive sentiment. Furthermore, this outlook has decreased by 6% in the past couple of months, raising concerns about employee morale and overall corporate health.

On a positive note, Teladoc Health has seen an estimated 1.3 million visitors to their webpage, up by 49% in recent months. This increase could signal a rise in customer interest and potential new customers. Additionally, the company has about 3,000 daily mobile app downloads, up by 12%, indicating improving customer acquisition metrics.

Customer engagement on social media presents a mixed picture. Teladoc Health's Instagram followers have increased by 8% to 16,000, showing growing interest. However, their Twitter followers remain unchanged at 18,000, suggesting stagnation in broader engagement efforts.

According to AltIndex's AI score, Teladoc Health boasts a score of 62, which acts as a buy signal based on a comprehensive analysis of fundamental, technical, and alternative data.

Conclusion and Recommendation

Teladoc Health faces mixed fortunes. There are notable concerns within the fundamental analysis, considering the decreases in revenue, net income, and EBITDA. Technical analysis supports a bearish outlook, compounded by insider stock sales and declining stock prices. On the alternative data front, increasing web visitors and mobile app downloads provide a glimmer of hope amidst other concerning employee and engagement metrics.

Overall, prospective investors should approach Teladoc Health with caution, weighing the downside risks against potential upside opportunities revealed by some positive trends. Existing shareholders should monitor future earnings reports closely, along with alternative metrics such as user growth and employee sentiment. Diversified investment strategies are recommended to manage risk effectively.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.